Journals / Mikrobiyoloji Bülteni / 2007 / Cilt: 41 - Sayı: 4

Seroprevalence of parvovirüs B19 in patients with chronic idiopathic thrombocytopenic

Kronik idiopatik trombositopenik purpura olgularında parvovirüs B19 seroprevalansı

Pages
597–602
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result although the rate of IgG positivity was found statistically higher in the ITP patients in our study, this data is inefficient for the evaluation of relationship between PV-B19 and chronic ITP, indicating the need for further studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although there are several studies indicating the relationship between parvovirus B19 (PV-B19) and acute idiopathic thrombocytopenic purpura (ITP) which is a form seen frequently in children, the data are not enough in terms of chronic ITP, which is a more insidious form frequently seen in adults.
📊
Key Findings & Data:The aim of this study was to investigate PV-B19 seroprevalence in adult chronic ITP cases diagnosed at the haematology clinics of Atatürk University Research Hospital in Erzurum (located in eastern Anatolia, Turkey).
💡
Conclusion & Impact:As a result although the rate of IgG positivity was found statistically higher in the ITP patients in our study, this data is inefficient for the evaluation of relationship between PV-B19 and chronic ITP, indicating the need for further studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Although there are several studies indicating the relationship between parvovirus B19 (PV-B19) and acute idiopathic thrombocytopenic purpura (ITP) which is a form seen frequently in children, the data are not enough in terms of chronic ITP, which is a more insidious form frequently seen in adults. The aim of this study was to investigate PV-B19 seroprevalence in adult chronic ITP cases diagnosed at the haematology clinics of Atatürk University Research Hospital in Erzurum (located in eastern Anatolia, Turkey). A total of 61 patients (38 female, 23 male; mean age: 34.4±11.2 years) and 60 healthy control subjects (30 female, 30 male; mean age: 35.6±9.6 years) were included to the study. All possible etiological agents and factors other than PV-B19 were eliminated on the basis of clinical and laboratory findings. PV-B19 antibodies were screened by ELISA method, and 73.7% (45/61) of the patients were found IgG, whereas 3.2% (2/61) were found IgM seropositive. In the control group, these rates were detected as 38.3% (23/60) and 1.6% (1/60), respectively. IgG antibodies were negative in the two patients and one control who were positive for IgM. The presence of PV-B19 DNA was investigated in all of the three IgM positive subjects, and was found positive in only one patient by real-time polymerase chain reaction (PCR). The difference between patient and control groups with regard to IgG seropositivity was found statistically significant (p<0.01), however statistical evaluation could not be performed for IgM seropositivity because of the low number of cases. As a result although the rate of IgG positivity was found statistically higher in the ITP patients in our study, this data is inefficient for the evaluation of relationship between PV-B19 and chronic ITP, indicating the need for further studies.

Özet

Küçük çocuklarda daha sık görülen akut idiopatik trombositopenik purpura (İTP) ile parvovirus B19 (PV-B19) arasındaki ilişkiyi gösteren çok sayıda çalışma olmasına rağmen, daha sinsi bir form olan ve erişkinlerde görülen kronik İTP ile ilgili yeterince veri bulunmamaktadır. Kronik İTP’lı erişkin hastalarda PV-B19 seroprevalansının araştırılmasını amaçlayan bu çalışmaya, Atatürk Üniversitesi Tıp Fakültesi, Araştırma Hastanesi Erişkin Hematoloji Kliniği’nde tanı konulmuş 61 olgu (38 kadın, 23 erkek; yaş ortalaması 34.4±11.2 yıl) ile sağlıklı 60 kontrol (30 kadın, 30 erkek; yaş ortalaması 35.6±9.6 yıl) birey dahil edilmiştir. Çalışmaya alınan tüm hastalarda PV-B19 dışındaki diğer olası etiyolojik ajanlar ve faktörler, klinik ve laboratuvar bulgularına dayanılarak elimine edilmiştir. PV-B19 antikorları ELISA yöntemi ile araştırılmış ve hastaların 45’inde (%73.7) IgG, ikisinde (%3.2) ise IgM seropozitifliği saptanmıştır. Bu oranlar kontrol grubunda sırasıyla %38.3 (23/60) ve %1.6 (1/60) olarak belirlenmiştir. PV-B19 IgM pozitif olan iki hasta ve bir kontrol, IgG yönünden negatif bulunmuştur. IgM pozitif olan üç örneğe gerçek zamanlı polimeraz zincir reaksiyonu (PCR) uygulanmış ve sadece hastalardan birinde PV-B19 DNA pozitif olarak tespit edilmiştir. PV-B19 IgG pozitifliği açısından iki grup arasında istatistiksel olarak anlamlı bir fark olduğu görülmüş (p<0.01), ancak olgu sayısının azlığı nedeniyle IgM pozitiflikleri yönünden istatistiksel karşılaştırma yapılamamıştır. Sonuç olarak, her ne kadar hasta grubunda anlamlı oranda yüksek IgG seropozitifliği saptanmış olsa da, bu veriler kronik İTP ve PV-B19 ile ilgili bir yorum yapmak için yeterli olmayıp ileri çalışmalara gereksinim olduğu açıktır.

🔖

Cite This Article

USLU, H., KİKİ, İ., ÖZBEK, A., ERDEM, F., AYYILDIZ, A. (2007). Seroprevalence of parvovirüs B19 in patients with chronic idiopathic thrombocytopenic. Mikrobiyoloji Bülteni, Cilt: 41 - Sayı: 4, 597–602. https://ajindex.com/articles/299040

References (15)

  1. Blacklow NR. Parvovirus, pp: 1054-6. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (eds), Harrison’s Principles of Internal Medicine. 2005,16thed. McGraw-Hill Co, New York
  2. Portmore AC. Parvoviruses (Erytema infectiosum, aplastic crisis), pp: 1439-46. In: Mandell GL, Bennett JE, Dolin R (eds), Principles and Practice of Infection Disease. 1995, 4th ed. Churchill-Livigstone, Philadelphia
  3. Arıbaş ET, Altındiş M. Parvovirus B19 enfeksiyonları. S.Ü Tıp Fak Derg 1996; 12: 257-61
  4. Wakamatsu C, Takakura F, Kojima E, et al. Screening blood donors of human parvovirus B19 and characterization of the results. Vox San 1999; 76:14-21
  5. Kok RH, Wolfhagen MJ, Klosters G. A syndrome resembling thrombotic thrombocytopenic purpura associated with human parvovirus B19 infection. Clin Infect Dis 2001; 32: 311-2
  6. Levine SP. Thrombocytopenia caused by immunologic platelet destruction, pp: 1533-54. In: Greer JP, Foerster J, Lukens JN, et al (eds), Wintrobe’s Clinical Hematology. 2003,11th ed. Lippincott Williams & Wilkins Co, Philadelphia
  7. Handin RI. Disorders of the platelet and vessel wall, pp: 673-80. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL (eds), Harrison’s Principles of Internal Medicine. 2005,16thed. McGraw-Hill Co, New York
  8. Murray JC, Kelley PK, Hogrefe WR, McClain KL. Childhood idiopathic thrombocytopenic purpura: association with human parvovirus B19 infection. Am J Pediatr Hematol Oncol 1994; 16: 314-9
  9. Heegaard ED, Rosthoj S, Petersen BL, Nielsen S, Karup Pedersen F, Hornsleth A. Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura. Acta Paediatr 1999; 88: 614-7
  10. Lefrere JJ, Courouce AM, Kaplan C. Parvovirus and idiopathic thrombocytopenic purpura. Lancet 1989; 1: 279
  11. Foreman NK, Oakhill A, Caul EO. Parvovirus-associated thrombocytopenic purpura. Lancet 1988; 2: 1426-7
  12. Assy N, Rosenthal E, Hazani A, Etzioni A, Baruch Y. Human parvovirus B19 infection associated with idiopathic thrombocytopenic purpura in a child following liver transplantation. J Hepatol 1997; 27: 934-6
  13. Aktepe OC, Yetgin S, Olcay L, Ozbek N. Human parvovirus B19 associated with idiopatic thrombocytopenic purpura. Pediatr Hematol Oncol 2004; 21: 421-6
  14. Kido S, Ito Y, Nishimura N, Kajita Y, Ozaki T. Human parvovirus B19 associated thrombocytopenic purpura. Acta Paediatr Jpn 1998; 40: 486-8
  15. Wehmeier A, Eis-Hubinger AM, Maas Enriquez M, Beckmann H. Parvovirus B19 in idi